159 related articles for article (PubMed ID: 8935990)
1. A novel Tth111I restriction fragment length polymorphism (RFLP) allows tracing of X-chromosome inactivation in the (Xid) heterozygote.
Shanmugam V; Chapman VM; Sell KW; Saha BK
Biochem Genet; 1996 Feb; 34(1-2):17-29. PubMed ID: 8935990
[TBL] [Abstract][Full Text] [Related]
2. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
3. A new molecular genetic diagnosis of the Btk(xid) mice.
Takagi Y; Masui N; Yasuda M; Ono S
Exp Anim; 2007 Jan; 56(1):63-6. PubMed ID: 17283893
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
[TBL] [Abstract][Full Text] [Related]
5. Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation.
Takada H; Kanegane H; Nomura A; Yamamoto K; Ihara K; Takahashi Y; Tsukada S; Miyawaki T; Hara T
Blood; 2004 Jan; 103(1):185-7. PubMed ID: 12958074
[TBL] [Abstract][Full Text] [Related]
6. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.
Rawlings DJ; Saffran DC; Tsukada S; Largaespada DA; Grimaldi JC; Cohen L; Mohr RN; Bazan JF; Howard M; Copeland NG
Science; 1993 Jul; 261(5119):358-61. PubMed ID: 8332901
[TBL] [Abstract][Full Text] [Related]
7. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
[TBL] [Abstract][Full Text] [Related]
8. Impaired expansion of mouse B cell progenitors lacking Btk.
Kerner JD; Appleby MW; Mohr RN; Chien S; Rawlings DJ; Maliszewski CR; Witte ON; Perlmutter RM
Immunity; 1995 Sep; 3(3):301-12. PubMed ID: 7552995
[TBL] [Abstract][Full Text] [Related]
9. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
10. BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis.
Potter M; Wax JS; Hansen CT; Kenny JJ
Int Immunol; 1999 Jul; 11(7):1059-64. PubMed ID: 10383938
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
Petro JB; Rahman SM; Ballard DW; Khan WN
J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
[TBL] [Abstract][Full Text] [Related]
12. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.
Duriez B; Duquesnoy P; Dastot F; Bougnères P; Amselem S; Goossens M
FEBS Lett; 1994 Jun; 346(2-3):165-70. PubMed ID: 8013627
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
[TBL] [Abstract][Full Text] [Related]
14. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
15. Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation.
Fearon ER; Winkelstein JA; Civin CI; Pardoll DM; Vogelstein B
N Engl J Med; 1987 Feb; 316(8):427-31. PubMed ID: 2880293
[TBL] [Abstract][Full Text] [Related]
16. Development of B lymphocytes in mice heterozygous for the X-linked immunodeficiency (xid) mutation. xid inhibits development of all splenic and lymph node B cells at a stage subsequent to their initial formation in bone marrow.
Forrester LM; Ansell JD; Micklem HS
J Exp Med; 1987 Apr; 165(4):949-58. PubMed ID: 3494095
[TBL] [Abstract][Full Text] [Related]
17. Twin carriers of X-linked agammaglobulinemia (XLA) due to germline mutation in the Btk gene.
Curtis SK; Hebert MD; Saha BK
Am J Med Genet; 2000 Jan; 90(3):229-32. PubMed ID: 10678660
[TBL] [Abstract][Full Text] [Related]
18. Carrier detection in typical and atypical X-linked agammaglobulinemia.
Conley ME; Puck JM
J Pediatr; 1988 May; 112(5):688-94. PubMed ID: 2896233
[TBL] [Abstract][Full Text] [Related]
19. Carrier determination for X-linked agammaglobulinemia using X inactivation analysis of purified B cells.
Alterman LA; de Alwis M; Genet S; Lovering R; Middleton-Price H; Morgan G; Jones A; Malcolm S; Levinsky RJ; Kinnon C
J Immunol Methods; 1993 Nov; 166(1):111-6. PubMed ID: 8228281
[TBL] [Abstract][Full Text] [Related]
20. Carrier detection in agammaglobulinemia by X chromosome inactivation analysis.
Miyashita T; Iwata T; Mizutani S; Kamoshita S; Kobayashi N
Acta Paediatr Jpn; 1992 Jun; 34(3):267-72. PubMed ID: 1354911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
